Patent · US Active

Diagnosis and risk stratification of fungal infections

US11592450B2 · kind B2 · utility

0Cited by

6References

18Claims

0Family size

Assignee

B.R.A.H.M.S GMBH · DE

Inventors

Thorsten Brenner · Mörlenbach, DE
Markus Alexander Weigand · Wettenberg, DE
Florian Uhle · Heidelberg, DE
Darius Wilson · Lörrach, DE

Key dates

Filing date	Aug 6, 2018
Grant date	Feb 28, 2023
Priority date	—
Expiry date	Aug 4, 2039

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to a method for the diagnosis and/or risk stratification of invasive fungal infections (IFI)/invasive fungal diseases (IFD) and in particular associated with sepsis or septic shock, wherein a determination of the marker proadrenomedullin (proADM) or a partial peptide or fragment thereof, in particular midregional proadrenomedullin (MR-proADM), or contained in a marker combination (panel, cluster), is carried out from a patient to be examined. Furthermore, the invention relates to a diagnostic assay and a kit for carrying out the method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.